Abiomed
ABMD
#1118
Rank
HK$133.57 B
Marketcap
HK$2,962
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Market capitalization of Abiomed (ABMD)

Last known market cap: HK$133.57 Billion

On August 1, 2024 Abiomed had a market cap of HK$133.57 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Abiomed from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$133.57 B-0.46%
2023HK$134.18 B-0.04%
2022HK$134.23 B5.35%
2021HK$127.42 B12.19%
2020HK$113.57 B89.49%
2019HK$59.93 B-47.74%
2018HK$114.68 B77.15%
2017HK$64.74 B70.8%
2016HK$37.90 B27.65%
2015HK$29.69 B144.86%
2014HK$12.12 B47.08%
2013HK$8.24 B103.57%
2012HK$4.05 B-26.79%
2011HK$5.53 B95.43%
2010HK$2.83 B11.55%
2009HK$2.53 B-45.35%
2008HK$4.64 B17.53%
2007HK$3.95 B34.6%
2006HK$2.93 B55.35%
2005HK$1.88 B-28.55%
2004HK$2.64 B130.06%
2003HK$1.14 B92.66%
2002HK$0.59 B-76.87%
2001HK$2.57 B-34.04%
2000HK$3.90 B57.34%
1999HK$2.48 B278.19%
1998HK$0.65 B-39.48%
1997HK$1.08 B65.79%
1996HK$0.65 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$70.60 B-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.011 T 657.05%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.19 B-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA